The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers
Open Access
- 1 November 2018
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Medicine
- Vol. 97 (46), e12912
- https://doi.org/10.1097/md.0000000000012912
Abstract
Autophagy is a mechanism which relies on lysosomes for clearance and recycling of abnormal proteins or organelles. Many studies have demonstrated that the deregulation of autophagy is associated with the development of various diseases including cancer. The use of autophagy inhibitors is an emerging trend in cancer treatment. However, the value of autophagy inhibitors remains under debate. Thus, a meta-analysis was performed, aiming to evaluate the clinical value of autophagy-inhibitor-based therapy. We searched for clinical studies that evaluated autophagy-inhibitor-based therapy in cancer. We extracted data from these studies to evaluate the relative risk (RR) of overall response rate (ORR), 6-month progression-free survival (PFS) rate, and 1-year overall survival (OS) rate. Seven clinical trials were identified (n = 293). Treatments included 2 combinations of hydroxychloroquine and gemcitabine, 1 combination of hydroxychloroquine and doxorubicin, 1 combination of chloroquine and radiation, 2 combinations of chloroquine, temozolomide, and radiation, and 1 hydroxychloroquine monotherapy. Autophagy-inhibitor-based therapy showed higher ORR (RR: 1.33, 95% confidence interval [CI]: 0.95–1.86, P = .009), PFS (RR: 1.72, 95% CI: 1.05–2.82, P = .000), OS (RR: 1.39, 95% CI: 1.11–1.75, P = .000) values than the therapy without inhibiting autophagy. This meta-analysis showed that autophagy-inhibitor-based therapy has better treatment response compared to chemotherapy or radiation therapy without inhibiting autophagy, which may provide a new strategy for the treatment of cancers.Keywords
This publication has 36 references indexed in Scilit:
- Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastasesRadiation Oncology, 2013
- Application and interpretation of current autophagy inhibitors and activatorsActa Pharmacologica Sinica, 2013
- Deconvoluting the context-dependent role for autophagy in cancerNature Reviews Cancer, 2012
- Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagyAutophagy, 2012
- Targeting autophagy during cancer therapy to improve clinical outcomesPharmacology & Therapeutics, 2011
- Autophagy and MetabolismScience, 2010
- A History of Cancer ChemotherapyCancer Research, 2008
- Autophagy: from phenomenology to molecular understanding in less than a decadeNature Reviews Molecular Cell Biology, 2007
- Adding Chloroquine to Conventional Treatment for Glioblastoma MultiformeAnnals of Internal Medicine, 2006